Workshop to Explore Adult Immunization Strategies as a Pathway for Prevention and Wellness

PRAGUE, CZECH REPUBLIC – The rapid growth in aging populations across the globe leads to the need for more attention to the risks of disease and ways to keep us healthy and active as we age. In this context, the success of childhood vaccination programs and schedules – with regard to lives saved and costs averted – in both developed and developing countries should serve as models for both health and economic policy for adult immunization strategies. The Global Coalition on Aging (GCOA) will lead this workshop, which aims to address the role of adult immunization to advance wellness and build effective prevention strategies across the life course. Experts on the topics of aging, health policy, economics, and immunization will engage in a dialogue on the value proposition of adult immunization and the path forward.

WHO:
Michael Hodin, Executive Director, Global Coalition on Aging and Adjunct Senior Fellow, Council on Foreign Relations (Moderator)
Jane Barratt, Secretary General, International Federation on Ageing
Stephen McMahon, Governing Board Member, International Alliance of Patients’ Organizations (IAPO) and Chairman, Irish Patients Association
Prof. Roman Prymula, MD, PhD, Director, University Hospital, Hradec Kralove and Chairman of Central European Vaccine Advisory Board (CEVAG)
Michael Waldholz, Pulitzer Prize-winning journalist and author, former managing editor at Bloomberg News/ Businessweek and former bureau chief at the Wall Street Journal

WHAT:
“Adult Immunization: A Central Driver of Prevention and Wellness”

Concurrent Panel Discussion during 11th Global Conference on Ageing
International Federation on Ageing Conference
This initiative was made possible through a collaboration with Pfizer.

WHEN:  
Thursday 31 May, 11:30 – 13:00 CEST

LEARN MORE:
For the recap video, click here.
For Stephen McMahon’s reflections from the panel, read “The Prague Illumination.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.

New Report From the Global Coalition on Aging Highlights the Connection Between Adult Immunization and Economic Health in Aging APEC Region

As leaders from across the Asia-Pacific Economic Cooperation (APEC) region convene in San Francisco over the next week, a new report from the Global Coalition on Aging (GCOA) points to investments in healthy aging as a growing economic imperative amid the region’s changing demographics. According to the new report, programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.